Processa Pharmaceuticals, Inc. Liabilities, Noncurrent
Processa Pharmaceuticals, Inc. (PCSA) had Liabilities, Noncurrent of $27.51 thousand as of 2015-09-30, per its 10-Q filed 2015-12-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2017-06-19
- 2015-09-30: Liabilities, Noncurrent $27.51K.
- 2015-06-30: Liabilities, Noncurrent $104.95K.
- 2015-03-31: Liabilities, Noncurrent $119.45K.
- 2014-12-31: Liabilities, Noncurrent $494.07K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2015-09-30 | $27.51K 10-Q · filed 2015-12-01 |
| 2015-06-30 | $104.95K 10-Q · filed 2015-08-19 |
| 2015-03-31 | $119.45K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $494.07K 10-K · filed 2017-06-19 |
| 2014-09-30 | $1.97M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.60M 10-Q · filed 2014-08-19 |
| 2014-03-31 | $1.09M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $145.46K 10-K · filed 2015-04-14 |
| 2013-09-30 | $156.20K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $92.28K 10-Q/A · filed 2013-09-06 |
| 2012-12-31 | $606.16K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |